Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial

BACKGROUND: Tenofovir disoproxil fumarate (TDF) decreases bone mineral density (BMD). We hypothesized that vitamin D3 (VITD3) would increase BMD in youth receiving TDF. METHODS: This was a randomized, double-blind, placebo-controlled trial of directly observed VITD3 vs placebo every 4 weeks for 48 w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Havens, Peter L, Stephensen, Charles B, Van Loan, Marta D, Schuster, Gertrud U, Woodhouse, Leslie R, Flynn, Patricia M, Gordon, Catherine M, Pan, Cynthia G, Rutledge, Brandy, Harris, D Robert, Price, Georgine, Baker, Alyne, Meyer, William A, Wilson, Craig M, Hazra, Rohan, Kapogiannis, Bill G, Mulligan, Kathleen
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Articles and Commentaries
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848310/
https://ncbi.nlm.nih.gov/pubmed/29020329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix753
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items